Therapeutic Goods (Charges) Amendment Regulations 2000 (No. 1)

Overview

The Therapeutic Goods (Charges) Amendment Regulations 2000 (No. 1) were enacted to address the need for increased funding to ensure the Therapeutic Goods Administration (TGA) could operate on a full cost recovery basis. This regulation, issued under the authority of the Parliamentary Secretary to the Minister for Health and Aged Care, amends the Therapeutic Goods (Charges) Regulations 1990. The primary policy objective of these amendments is to adjust the annual charges for maintaining the registration and listing of therapeutic goods in the Australian Register of Therapeutic Goods (the Register), thus reflecting the operational costs of the TGA. This adjustment was necessary to ensure the sustainable management and regulation of therapeutic goods, maintaining the high standards of quality, safety, and efficacy expected by the Australian public. The increases in charges were determined after extensive consultation with industry stakeholders and are directly linked to the cost recovery requirements of the TGA.

Scope and Application

The Therapeutic Goods (Charges) Amendment Regulations 2000 (No. 1) pertains to entities and individuals involved in the manufacture, supply, importation, or exportation of therapeutic goods within Australia. These therapeutic goods must be registered or listed in the Australian Register of Therapeutic Goods unless exempt under the Therapeutic Goods Act 1989. The primary purpose of these regulations is to adjust the annual charges for maintaining these registrations and listings, in line with the government's goal of ensuring that the Therapeutic Goods Administration operates on a full cost-recovery basis. The amendments cover various categories of therapeutic goods, including prescription-only medicines, controlled drugs, and other medicinal products. The increased charges are designed to align with the operating costs of the Therapeutic Goods Administration and reflect the adjustments made to the Therapeutic Goods (Charges) Regulations 1990. The regulations commenced on 1 July 2000 and apply across the Commonwealth of Australia. The scope of the regulations is specified in the schedule, detailing the specific increases for different categories of therapeutic goods.

Key Provisions

The Therapeutic Goods (Charges) Amendment Regulations 2000 (No. 1) primarily serve to adjust the annual charges applicable for maintaining the registration or listing of therapeutic goods in the Australian Register of Therapeutic Goods. As stipulated in subsection 4(1) of the Therapeutic Goods (Charges) Act 1989 (the Act), these charges are intended to cover the cost of maintaining these registrations and listings. Subsection 4(1A) further explains that where therapeutic goods are grouped under the same registration or listing number, a single annual charge applies. The regulations amend the Therapeutic Goods (Charges) Regulations 1990 to increase these charges, aiming to achieve full cost recovery for the Therapeutic Goods Administration's operations. The amended regulations impose specific financial obligations on entities responsible for maintaining the registration or listing of therapeutic goods. For example, under the new provisions, entities must now pay an annual charge of $950 for maintaining registrations of drugs that are principally prescription-only medicines or controlled drugs, up from $750. Similarly, the charge for maintaining registrable medicines that are not prescription-only or controlled drugs has increased from $455 to $465. For listable medicines, the charge has risen from $270 to $350. Grouped therapeutic goods are also subject to these increased charges, with $950 now required for maintaining grouped prescription-only or controlled drugs and $465 for other grouped medicines. Additionally, listings of grouped listable medicines now attract a charge of $350, up from $270. Failure to comply with the new charge requirements as outlined in the regulations may result in legal consequences. While the explanatory statement does not explicitly detail penalties for non-compliance, the Therapeutic Goods Act 1989 and associated regulations typically outline potential civil or administrative penalties for breaches. Such penalties could include fines or other enforcement actions by the Therapeutic Goods Administration to ensure compliance with the legislative requirements. The exact penalties would need to be referred to in the primary legislation or related regulations for precise details.